ARM needed this deal badly and an IPO valuation will be problematic. ARM is now facing competition from an army of competitors from the RISCV camp. They can only hope that the IPO valuation will be based on their legacy revenue stream since in the future, IP licensing will trend towards and order of magnitude lower than they currently are. The party is over and ARM knows it.